Insulet rises after Q1 results beat

Insulet

09/05/2025 15:11

Updates

** Medical device maker Insulet's PODD.O shares rise as much as 16.6% hitting a two-year high of $311.65

** Stock is set for its best day in over two years, if gains hold

** Insulet late on Thursday beat Q1 profit estimates, buoyed by strong demand for its wearable insulin pumps

** Company earned $1.02 per share, above analysts' average estimate of 80 cents per share - data compiled by LSEG

** Company now expects its annual revenue to grow between 19% and 22%, compared with its previous projection of 16% to 20%

** Company's Q1 total revenue increased 28.8% to $569 million, compared with analysts' estimates of $543.4 million

** Including session's moves, stock up 15.2% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))